We are taking collective action to end the COVID-19 pandemic. Please see this webpage for updates on the local COVID response, vaccine access and services in the East Bay as well as guidance and resources for people living with HIV and HIV providers. It is important that we combat stigma and misinformation, protect each other and stay safely connected as a community during this global pandemic.
Updated May 19, 2021 On April 23, after a 10-day pause, the CDC voted to resume vaccinations with the Johnson & Johnson (J&J or Janssen) vaccine for people ages 18+ because the benefits far outweigh the risks of very rare blood clots. Meeting slides and data updates discussed at the April 23rd CDC Advisory Committee … Continued
Updates on the East Bay HIV strategic plan are posted on this webpage. This is a community-driven “living” East Bay HIV strategic plan that is flexible and responsive to local needs, addresses structural inequities, and is used to make systemic change to achieve our vision of an East Bay with zero HIV stigma, zero health disparities, and zero new HIV transmissions.
On December 4, 2020 in commemoration of World AIDS Day, 100 people came together to celebrate our collective resistance, resilience, strength and beauty with music, poetry, song and dance; honor people in the East Bay HIV community; and to share our draft of the 5-year East Bay HIV strategy. Please click here to learn more … Continued
New HIV/STI Prevention resources available on the East Bay Getting to Zero website! The following PrEP and Prevention resources for navigators, clinicians, and patients have been added to our website. PrEP Resources Truvada® has gone generic! Generic TDF/FTC (Truvada®) Fact Sheet for PrEP patients and PLWH – San Francisco Department of Public Health How to … Continued
See the Generic TDF/FTC (Truvada®) Fact Sheet from the San Francisco Department of Public Health for details on how this will affect access to PrEP. Highlights from the Fact Sheet: The Gilead patent on Truvada® expired on September 30, 2020. Now that the patent has expired, Teva Pharmaceutical Industries Ltd., has the exclusive rights to … Continued